Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus

Transplantation Proceedings

Volumn 43, Issue 8, 2011, Pages 2954-2956

  Kurnatowska, I ^a   Krawczyk, J ^a   Oleksik, T ^a   Nowicki, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TACROLIMUS;

ADULT; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG RELEASE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CREATININE; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 80054768606     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.08.021     Document Type: Conference Paper

References (10)

1. H.U. Meier-Kriesche, J.D. Schold, and T.R. Srinivas Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 2004 378
2. B.J. Nankivell, R.J. Borrows, and C.L. Fung The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326
3. G. Opelz, B. Dohler Collaborative Transplant Study Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation Transplantation 87 2009 795
4. S. De Geest, L. Borgermans, and H. Gemoets Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients Transplantation 59 1995 340
5. F.L. Weng, A.K. Israni, and M.M. Joffe Race and electronically measured adherence to immunosuppressive medications after decreased donor renal transplantation J Am Soc Nephrol 16 2005 1839
6. R. Alloway, S. Steinberg, and K. Khalil Two years postconversion from a Prograf-based regiment to a once daily-tacrolimus extended-release formulation in stable kidney transplant recipients Transplantation 83 2007 1648
7. M. Merli, M. Di Menna, and M. Giusto Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient Transplant Proc 42 2010 1322 1324
8. J.M. Hougardy, N. Broeders, and M. Kianda Conversion from Prograf to Advagraf among kidney transpalnt recipients results in sustained decrease in tacrolimus exposure Transplantation 91 2011 566
9. A. Meule, L. Poli, and I. Nofroni Once daily tacrolimus formulation: monitoring of plasma levels, graft function and cardiovascular risk factors Transplant Proc 42 2010 1317
10. F. Tinti, A. Meule, and L. Poli Improvement of graft function after conversion to once daily tacrolimus of stable kidney transplant patients Transplant Proc 42 2010 4047